Healthcare IT News February 10, 2023
Andrea Fox

The group’s citizens petition asks the U.S. Food and Drug Administration to repurpose its Final Guidance on Clinical Decision Support Software, claiming it’s at odds with other federal policies.

The CDS Coalition is asking the U.S. Food and Drug Administration to pull back on its clinical decision support guidance in order to ensure that the agency better balances its regulatory oversight with the healthcare sector’s need for innovation while comporting with the statutory language of the 21st Century Cures Act.

‘Flagrant’ disregard for Congressional law and intent

The coalition’s stakeholders – clinical decision support software developers, patient advocacy organizations, clinical societies, healthcare providers and healthcare payers – say FDA’s guidance exceeds Congress’s statutory definitions of what is considered CDS...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: EMR / EHR, FDA, Govt Agencies, Health IT, Provider, Technology
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know

Share This Article